vimarsana.com
Home
Live Updates
Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform : vimarsana.com
Degron Therapeutics Raises $22M Series A Financing to Accelerate Growth and Expand Molecular-Glue-Based Targeted Protein Degradation Drug Discovery Platform
/PRNewswire/ -- Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable...
Related Keywords
Shanghai ,
China ,
Jing Yu ,
Shanxi ,
Lily Zou ,
Yong Cang ,
Shanghaitech University ,
,
Dyee Capital ,
Baidu Venture ,
Neux Capital ,
Yuanbio Venture ,
Degron Therapeutics ,
Med Fine Capital ,
vimarsana.com © 2020. All Rights Reserved.